---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-081912"
form_type: "8-K"
ticker: "VSEE"
cik: "0001864531"
company_name: "VSEE HEALTH, INC."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:11:36.169813+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# VSee Health expands board to seven, appoints Fairfax and Wickersham as Class III directors

## Summary
- Board increased from 5 to 7 members; Fairfax and Wickersham appointed as Class III directors effective July 17, 2024.
- Fairfax appointed to Audit Committee and as chair of Nominating Committee; Wickersham appointed chair of Compensation Committee.
- Fairfax is EVP & General Counsel of Metro (Harris County transit) and previously SVP at American Capital; both directors independent per Nasdaq.
- Wickersham held a $224k secured convertible note from subsidiary iDoc, satisfied with 114k shares; no other related-party transactions.
- Director compensation has not yet been determined by the Board.

## SEC filing metadata
- accession: 0001104659-24-081912
- form_type: 8-K
- ticker: VSEE
- cik: 0001864531
- company_name: VSEE HEALTH, INC.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1864531/000110465924081912/0001104659-24-081912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1864531/000110465924081912/tm2419980d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-081912
- JSON: https://secwatch.observer/filing/0001104659-24-081912.json
- Plain text: https://secwatch.observer/filing/0001104659-24-081912.txt

## Key facts
- Executive change
  David L. Wickersham was appointed as Class III Director at VSEE HEALTH, INC..
  - Action: appointed
  - Role: Class III Director
  source text: On July 17, 2024, the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000110465924081912/0001104659-24-081912-index.htm
- Executive change
  Cydonii V. Fairfax was appointed as Class III Director at VSEE HEALTH, INC..
  - Action: appointed
  - Role: Class III Director
  source text: On July 17, 2024, the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000110465924081912/0001104659-24-081912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.